Moderna Gains 7% as Cowen Upgrades MRNA Stock from Market Perform to Outperform
In addition to noting that Moderna will lead the RSV vaccine market, Cowen also referred to major opinion leaders’ belief in the pharmaceutical company competing in a “three-player vaccine market”.